학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 297건 | 목록 1~20
Editorial & Opinion
Puig N; Hematology Department IBSAL, Instituto de Biología Molecular y Celular del Cáncer-Consejo Superior de Investigaciones Científicas (IBMCC-CSIC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Salamanca Spain.; Agulló C; Clinical Biochemistry Department Hospital Universitario de Salamanca Salamanca Spain.; Paiva B; Clínica Universidad de Navarra, CUN, CIMA, IDISNA, CIBERONC CB16/12/00369 Pamplona Spain.; Cedena MT; Hospital Universitario 12 de Octubre, Complutense University, i + 12, CNIO, CIBERONC, CB16/12/00369 Madrid Spain.; Rosiñol L; Hospital Clinic, Institut d'Investigacions Biomédiques August Pi I Sunyer (IDIBAPS) Barcelona Spain.; Contreras T; Clinical Biochemistry Department Hospital Universitario de Salamanca Salamanca Spain.; Martínez-López J; Hospital Universitario 12 de Octubre, Complutense University, i + 12, CNIO, CIBERONC, CB16/12/00369 Madrid Spain.; Oriol A; Institut Català d'Oncologia, Institut Josep Carreras, Hospital Germans Trias I Pujol Barcelona Spain.; Blanchard MJ; Hematology Department Hospital Ramón y Cajal Madrid Spain.; Ríos-Tamayo R; Hospital Universitario Virgen de las Nievels, Ibs Granada Spain.; Sureda A; Institut Catalá d'Oncologia- l'Hospitalet, IDIBELL, Universitat de Barcelona Barcelona Spain.; Lakhwani S; Hospital Universitario de Canarias Santa Cruz de Tenerife Spain.; de la Rubia J; Hematology Department University Hospital La Fe and School of Medicine and Dentistry, Catholic University of Valencia, CIBERONC CD16/12/00284 Valencia Spain.; Cabañas V; Hospital Universitario Virgen de la Arrixaca, IMIB Murcia Spain.; de Arriba F; Hospital Morales Meseguer, IMIB-Pascual Parrilla, Universidad de Murcia Murcia Spain.; Paricio M; Hospital Clínico Universitario Lozano Blesa, Instituto Investigacion Sanitaria Aragon Zaragoza Spain.; Iñigo MB; Hospital Clínico San Carlos Madrid Spain.; González-Calle V; Hematology Department IBSAL, Instituto de Biología Molecular y Celular del Cáncer-Consejo Superior de Investigaciones Científicas (IBMCC-CSIC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Salamanca Spain.; Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL), Universidad de Cantabria Santander Spain.; Castro S; Clinical Biochemistry Department Hospital Universitario de Salamanca Salamanca Spain.; Bargay J; Hospital Universitario Son Llàtzer, IdIsBa Palma de Mallorca Spain.; Bladé J; Hospital Clinic, Institut d'Investigacions Biomédiques August Pi I Sunyer (IDIBAPS) Barcelona Spain.; San Miguel JF; Clínica Universidad de Navarra, CUN, CIMA, IDISNA, CIBERONC CB16/12/00369 Pamplona Spain.; Lahuerta JJ; Hospital Universitario 12 de Octubre, Complutense University, i + 12, CNIO, CIBERONC, CB16/12/00369 Madrid Spain.; Mateos MV; Hematology Department IBSAL, Instituto de Biología Molecular y Celular del Cáncer-Consejo Superior de Investigaciones Científicas (IBMCC-CSIC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) Salamanca Spain.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Gerotziafas G; Sorbonne University, INSERM UMR_S_938, Saint-Antoine Research Center (CRSA), Research Department 'Cancer, Vessels, Biology and Therapeutics' (CaVITE), Research Group 'Cancer-Angiogenesis-Thrombosis and Haemostasis,' Thrombosis Center, University Institute of Cancerology (UIC), Saint Antoine University Hospital Assistance Publique Hôpitaux de Paris (AP-HP) Paris France.; VAS-European Independent Foundation in Angiology/Vascular Medicine Milan Italy.; Fotiou D; Department of Clinical Therapeutics Plasma Cell Dyscrasias Unit, National and Kapodistrian University of Athens, School of Medicine Athens Greece.; Nijhof I; Department of Hematology Amsterdam University Medical Center Amsterdam The Netherlands.; Department of Internal Medicine St. Antonius Hospital Nieuwegein The Netherlands.; Department of Hematology St. Antonius Hospital Nieuwegein The Netherlands.; Ay C; Department of Medicine I, Comprehensive Cancer Center Vienna, Division of Hematology and Hemostaseology Medical University of Vienna Vienna Austria.; Lecumberri R; Hematology Service Clínica Universidad de Navarra Pamplona Spain.; CIBERCV, Carlos III Health Institute Madrid Spain.; Laroca A; Division of Hematology University of Torino, AOU Città della Salute e della Scienza di Torino Torino Italy.; Cook G; Leeds Institute of Clinical Trial Research & Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust Leeds UK.; Engelhardt M; Department of Hematology and Oncology, Interdisciplinary Cancer Center and Comprehensive Cancer Center Freiburg, Faculty of Freiburg University of Freiburg Freiburg Germany.; Zweegman S; Department of Hematology Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands.; Delforge M; Department of Hematology University Hospital Leuven Leuven Belgium.; Maraveyas A; Queen's Centre for Oncology and Haematology, Clinical Sciences Centre, Hull York Medical School and Hull University Teaching Hospitals NHS Trust Hull UK.; Lefkou E; Sorbonne University, INSERM UMR_S_938, Saint-Antoine Research Center (CRSA), Research Department 'Cancer, Vessels, Biology and Therapeutics' (CaVITE), Research Group 'Cancer-Angiogenesis-Thrombosis and Haemostasis,' Thrombosis Center, University Institute of Cancerology (UIC), Saint Antoine University Hospital Assistance Publique Hôpitaux de Paris (AP-HP) Paris France.; VAS-European Independent Foundation in Angiology/Vascular Medicine Milan Italy.; Marchetti M; Department of Immunohematology and Transfusion Medicine Hospital Papa Giovanni XXIII Bergamo Italy.; Department of Medicine and Surgery University of Milano-Bicocca Monza Italy.; Van de Donk NWCJ; Department of Hematology Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands.; Gay F; Division of Hematology University of Torino, AOU Città della Salute e della Scienza di Torino Torino Italy.; Ludwig H; First Department of Medicine Center for Oncology, Hematology, and Palliative Care, Wilhelminen Cancer Research Institute, Clinic Ottakring Vienna Austria.; Einsele H; Department of Internal Medicine II University Hospital Wurzburg Wurzburg Germany.; San Miguel JF; Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.; Dimopoulos MA; Department of Clinical Therapeutics Plasma Cell Dyscrasias Unit, National and Kapodistrian University of Athens, School of Medicine Athens Greece.; Department of Medicine Korea University Seoul South Korea.; Boccadoro M; Division of Hematology University of Torino, AOU Città della Salute e della Scienza di Torino Torino Italy.; Sonneveld P; Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.; Falanga A; Department of Immunohematology and Transfusion Medicine Hospital Papa Giovanni XXIII Bergamo Italy.; Department of Medicine and Surgery University of Milano-Bicocca Monza Italy.; Terpos E; Department of Clinical Therapeutics Plasma Cell Dyscrasias Unit, National and Kapodistrian University of Athens, School of Medicine Athens Greece.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Manubens A; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.; Paiva B; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.; Gutiérrez NC; Department of Hematology University Hospital of Salamanca, IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC Salamanca Spain.; Fernandez M; Instituto de Investigación Hospital Universitario 12 de Octubre Madrid Spain.; Calasanz MJ; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.; Rosiñol L; Hospital Clinic i Provincial de Barcelona, IDIBAPS Barcelona Spain.; Oriol A; Hospital Universitari Germans Trias i Pujol Badalona Spain.; Blanchard MJ; Hospital Ramón y Cajal Madrid Spain.; Carrillo E; Complejo Hospitalario Regional Virgen Del Rocío Sevilla Spain.; Benavente C; Hospital Clínico San Carlos Madrid Spain.; Martínez-López J; Instituto de Investigación Hospital Universitario 12 de Octubre Madrid Spain.; Bargay J; Hospital Universitario Son Llàtzer Palma de Mallorca Spain.; Hernández MT; Hospital Universitario De Canarias La Laguna Spain.; de la Rubia J; Hospital Universitario la Fe, Instituto de Investigación Sanitaria La Fe, School of Medicine and Dentistry Catholic University of Valencia Valencia Spain.; González Y; Hospital Universitari Dr. Josep Trueta de Girona Girona Spain.; Paricio M; Hospital Clínico Universitario Lozano Blesa Zaragoza Spain.; de Arriba F; Hospital General Universitario Morales Meseguer, IMIB-Pascual Parrilla. Universidad de Murcia Murcia Spain.; Ocio EM; Hospital Universitario Marqués de Valdecilla (IDIVAL) Universidad de Cantabria Santander Spain.; Teruel AI; Hospital Clínico Universitario de Valencia Valencia Spain.; de la Guia AL; Hospital Universitario La Paz Madrid Spain.; Sirvent M; Hospital Universitario de Donostia San Sebastián Spain.; Gironella M; Hospital Universitari Vall d'Hebron Barcelona Spain.; Sampol A; Hospital Universitario Son Espases Palma de Mallorca Spain.; Arguiñano JM; Hospital Universitario de Navarra Pamplona Spain.; Cabrera C; Hospital Universitario de Cáceres Cáceres Spain.; Alegre A; Hospital Universitario de La Princesa Madrid Spain.; Granell M; Hospital de la Santa Creu i Sant Pau Barcelona Spain.; Cabañas V; Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Pascual Parrilla University of Murcia Murcia Spain.; Núñez-Córdoba JM; Cancer Center Clínica Universidad de Navarra Pamplona Spain.; Mateos MV; Department of Hematology University Hospital of Salamanca, IBSAL, Cancer Research Center-IBMCC (USAL-CSIC), CIBERONC Salamanca Spain.; Lahuerta JJ; Instituto de Investigación Hospital Universitario 12 de Octubre Madrid Spain.; San Miguel JF; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.; Bladé J; Hospital Clinic i Provincial de Barcelona, IDIBAPS Barcelona Spain.; Rodriguez-Otero P; Cancer Center Clínica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.
Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Academic Journal
Zabaleta A; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Puig N; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Cedena MT; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain.; Oliver-Caldes A; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Perez JJ; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Moreno C; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Tamariz-Amador LE; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Rodriguez-Otero P; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Prosper F; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Gonzalez-Calle V; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; López-Corral L; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Rey-Búa B; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Puertas B; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Mirás F; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain.; Sánchez-Pina JM; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain.; López-Muñoz N; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain.; Juan M; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; González-Navarro EA; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Urbano Á; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; de Larrea CF; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Blade J; Hospital Clinic de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.; Lahuerta JJ; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; Martinez-Lopez J; Servicio de Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain.; Mateos MV; Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca, Salamanca, Spain.; San Miguel JF; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.; Paiva B; Cancer Center Clinica Universidad de Navarra (CCUN), Centro de Investigacion Medica Aplicada (CIMA), Instituto de Investigacion Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Academic Journal
Avet-Loiseau H; Unité de Genomique du Myélome, Institut National de la Santé et de la Recherche Médicale, University Cancer Center of Toulouse, Toulouse, France.; Davies FE; Perlmutter Cancer Center, NYU Langone Health, New York, NY.; Samur MK; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA.; Corre J; Unité de Genomique du Myélome, Institut National de la Santé et de la Recherche Médicale, University Cancer Center of Toulouse, Toulouse, France.; D'Agostino M; Division of Hematology, AOU Città della Salute e della Scienza di Torino, Torino, Italy.; University of Torino and Department of Molecular Biotechnology and Health Sciences, Torino, Italy.; Kaiser MF; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, United Kingdom.; Department of Haematology, The Royal Marsden Hospital, London, United Kingdom.; Raab MS; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Weinhold N; Department of Medicine V, Heidelberg Myeloma Center, University Hospital and Medical Faculty Heidelberg, Heidelberg University, Heidelberg, Germany.; Gutierrez NC; Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC, Salamanca, Spain.; Paiva B; Cancer Center Clínica Universidad de Navarra (CCUN), Centro de Investigación Médica Aplicada (CIMA LAB Diagnostics), IDISNA, CIBERONC, Pamplona, Spain.; Neri P; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.; Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Maura F; Division of Myeloma, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL.; Walker BA; Division of Hematology and Oncology, School of Medicine, Melvin and Bren Simon Comprehensive Cancer Center, Indiana University, Indianapolis, IN.; Bustoros M; Division of Hematology and Medical Oncology, Joan and Sanford I. Weill Department of Medicine, Sandra & Edward Meyer Cancer Center, Weill Cornell Medicine, New York, NY.; Stewart AK; Division of Hematology-Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada.; Usmani SZ; Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Hillengass J; Department of Medicine-Myeloma, Roswell Park Comprehensive Cancer Center, Buffalo, NY.; Chng WJ; Department of Medical Oncology, National University Cancer Institute, and Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.; Keats JJ; Integrated Cancer Genomics Division, Translational Genomics Research Institute, Phoenix, AZ.; Martinez-Lopez J; Hospital 12 de Octubre, i+12, School of Medicine Universidad Complutense, CNIO, Madrid, Spain.; Sperling AS; Dana-Farber Cancer Institute, Boston, MA.; Touzeau C; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.; Zhan F; Department of Internal Medicine, Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR.; Raje NS; Department of Hematology/Oncology, Center for Multiple Myeloma, Harvard Medical School, Massachusetts General Hospital, Boston, MA.; Cavo M; Dipartimento di Scienze Mediche e Chirurgiche, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Università di Bologna, Bologna, Italy.; Bolli N; Department of Oncology and Onco-Hematology, University of Milan and Hematology Section Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Ghobrial IM; Department of Medical Oncology, Center for Early Detection and Interception of Blood Cancers, Dana-Farber Cancer Institute, Boston, MA.; Dhodapkar MV; Emory University School of Medicine, Atlanta, GA.; Jagannath S; Icahn School of Medicine at Mount Sinai, New York, NY.; Spencer A; Department of Haematology, The Alfred Hospital and Monash University, Melbourne, Australia.; Parekh S; Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY.; Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, Canada.; Lonial S; Winship Cancer Institute, Emory University, Atlanta, GA.; Sonneveld P; Department of Hematology, EMN/Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Bergsagel L; Division of Hematology, Mayo Clinic, Phoenix, AZ.; Orlowski RZ; Departments of Lymphoma/Myeloma and Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.; Morgan G; Perlmutter Cancer Center, NYU Langone Health, New York, NY.; Mateos MV; Departamento de Hematología, Hospital Universitario de Salamanca, (HUSA/IBSAL), Centro de Investigación del Cáncer-IBMCC (CSIC/USAL), CIBERONC, Salamanca, Spain.; Rajkumar SV; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.; San Miguel JF; Cancer Center Clínica Universidad de Navarra (CCUN), CIMA, CIBERONC, IDISNA, Pamplona, Spain.; Anderson KC; Department of Medical Oncology, Jerome Lipper Multiple Myeloma Center, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.; Moreau P; Hematology Department, University Hospital Hôtel-Dieu, Nantes, France.; Kumar S; Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN.; Prósper F; Hematology and Cell Therapy and Program of Hematology-Oncology CIMA, Clinica Universidad de Navarra, IdISNA, CIBERONC, Pamplona, Spain.; Munshi NC; Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE
Academic Journal
Hematology. Apr2012 Supplement 1, Vol. 17, p3-s6. 4p.
Academic Journal
BLOOD
r-FISABIO. Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Institut de Recerca Germans Trias i Pujol (IGTP)
Digital.CSIC. Repositorio Institucional del CSIC
Consejo Superior de Investigaciones Científicas (CSIC)
r-FISABIO: Repositorio Institucional de Producción Científica
instname
RISalud-ANDALUCIA. Repositorio Institucional de Salud de Andalucía
Blood Advances
검색 결과 제한하기
제한된 항목
[AR] San Miguel, Jesús F
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어